Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre.

OBJECTIVE To study the impact of various clinicopathological factors on short-term survival in a cohort of breast cancer patients treated at the University of Malaya Medical Centre (UMMC). METHODS All cases of breast cancer treated at UMMC from January 1999 to June 2001, except for stage IV disease, were included in the study. Survival analysis was carried out using Kaplan-Meier for univariate analysis and Cox regression for multivariate analysis. The log-rank test was used to test the significance of differences between the different survival curves. RESULTS A total of 385 patients were included. The mean patient age at presentation was 50.3 years (SD, 11.4); 198 (51.4%) patients had lymph node-positive disease, and 187 (48.6%) had node-negative disease. The mean follow-up period was 18.7 months (SD, 8.8). The Malay ethnic group, tumours of larger size, node-positive disease, more than five positive lymph nodes, oestrogen receptor (ER) negativity and the presence of lymphovascular invasion were significant prognostic factors for shorter recurrence-free survival (RFS) in the univariate analysis. In the multivariate analysis, ER negativity was the only independent adverse prognostic factor for RFS. For overall survival (OS), tumours of larger size, node-positive disease, more than five positive lymph nodes, ER negativity and high grade tumours were associated with significantly shorter OS. However, more than five positive lymph nodes was the only independent prognostic factor for shorter OS in the multivariate analysis. Further multivariate analysis of the patients with node-positive disease showed that the Malay ethnic group, ER negativity and more than five positive lymph nodes were independent prognostic factors for shorter RFS. On the other hand, ER negativity and more than five positive lymph nodes were independent negative prognostic factors for OS in this subgroup of patients. CONCLUSION The evaluation of various prognostic factors would provide useful information on disease progression in local patients, especially for the planning of adjuvant therapies and follow-up protocols. Differences in the pattern of breast cancer among the different ethnic groups in Malaysia warrant further studies.

[1]  K Vajda,et al.  [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.

[2]  V. Kosma,et al.  The changing importance of prognostic factors in breast cancer during long‐term follow‐up , 1992, International journal of cancer.

[3]  J. Bonneterre,et al.  Age as a prognostic factor in breast cancer. , 1998, Anticancer research.

[4]  E. Rimm,et al.  A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome , 2000, Cancer.

[5]  C. Silfverswärd,et al.  Carcinoma of the breast in women under 30 years of age. A clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958–1968 , 1977, Cancer.

[6]  N. de Klerk,et al.  Histological Grading in Breast Cancer: Interobserver Agreement, and Relation to Other Prognostic Factors Including Ploidy , 1992, Pathology.

[7]  G. Robbins,et al.  Long‐term followup of breast cancer patients: The 30‐year report , 1974, Cancer.

[8]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[9]  G M Clark,et al.  Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. , 1994, Journal of the National Cancer Institute.

[10]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[11]  I. Mittra,et al.  A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? , 1991, European journal of cancer.

[12]  P. Saigo,et al.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Sauerbrei,et al.  Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. , 2001, European journal of cancer.

[14]  K. Kunze,et al.  Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance. , 1990, Pathology, research and practice.

[15]  P. Hall,et al.  Prognostic and predictive factors. , 2004, Methods in molecular medicine.

[16]  G M Clark,et al.  Steroid receptors and other prognostic factors in primary breast cancer. , 1988, Seminars in oncology.

[17]  P. Mullins,et al.  Progesterone and estrogen receptors as prognostic variables in breast cancer. , 1983, Cancer research.

[18]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Koscielny,et al.  Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. , 1984, British Journal of Cancer.

[20]  W. Spanos,et al.  Breast cancer in women aged 30 and under , 1982, Cancer.

[21]  B W Ruffner,et al.  Breast carcinoma. , 1975, Virginia medical monthly.

[22]  W D Dupont,et al.  Histologic grading of breast carcinoma. A reproducibility study , 1994, Cancer.

[23]  I. Fentiman,et al.  A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome , 2002, Cancer.

[24]  C. Pyke.  Prognostic factors and the curability of breast cancer. , 1996, The Australian and New Zealand journal of surgery.

[25]  H. Høst,et al.  Age as a prognostic factor in breast cancer , 1986, Cancer.

[26]  G. Ribeiro,et al.  The prognosis of breast carcinoma in women aged less than 40 years. , 1981, Clinical radiology.

[27]  S Hellman,et al.  Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  E. J. Gregory,et al.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.

[29]  H. Adami,et al.  Prognostic implication of estrogen receptor content in breast cancer , 2005, Breast Cancer Research and Treatment.

[30]  U. Chetty,et al.  Prospective evaluation of prognostic factors in operable breast cancer. , 1996, British Journal of Cancer.

[31]  D. Schultz,et al.  Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome , 1992, Cancer.

[32]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[33]  L. Horwood,et al.  Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years. , 1983, British medical journal.

[34]  J. Olson,et al.  Prognostic significance of the number of lymph nodes examined in patients with lymph node‐negative breast carcinoma , 2001, Cancer.